Therefore, we believe that combination H2O2-generating chemotherapeutic treatment of PCa with antioxidants like MSKE, that targets superoxide but not H2O2, may be a possible therapeutic target for PCa patients with the Ala/Ala genotype of SOD2. The gene discussed is SOD2; the disease is posterior cortical atrophy.